Finance

Lists
BE50:FRA
CNS Pharmaceuticals Inc
€0.61
0.00%
(0.00) 1D
Jul 22, 8:01:39 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for BE50...
Mkt. cap
7.53M
Volume
0.00
52-wk high
€0.61
52-wk low
€0.61
No. of employees
8
Mkt. cap
7.53M
Volume
0.00
52-wk high
€0.61
52-wk low
€0.61
No. of employees
8
About CNS Pharmaceuticals Inc
CEO-
Employees8
Founded2017
HeadquartersHouston, Texas, United States
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2.20M
3.17M
3.54M
1.20M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.06M
2.82M
1.43M
1.50M
Operating expense
3.25M
5.99M
4.98M
2.70M
Total operating expenses
3.25M
5.99M
4.98M
2.70M
Operating income
-3.25M
-5.99M
-4.98M
-2.70M
Other non operating income
-
-2.56K
-
-
EBT including unusual items
-3.22M
-5.96M
-4.94M
-2.59M
EBT excluding unusual items
-3.22M
-5.96M
-4.94M
-2.59M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3.22M
-5.96M
-4.94M
-2.59M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
37.02K
35.60K
44.27K
116.00K
Interest expense
-2.12K
-2.72K
-6.11K
-4.00K
Net interest expenses
34.91K
32.88K
38.16K
112.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.25M
-5.99M
-4.97M
-2.69M
Gain or loss from assets sale
-
2.56K
-
-
AI content may include mistakes. Learn more
Google apps